As observations in the past do not necessarily hold into the future, predicting future cancer
occurrence is fraught with uncertainty. Nevertheless, predictions can aid health planners in …

Background: Monitoring the evolution of the cancer burden in Europe is of great value.
Estimates of the cancer burden in Europe have been published for 2004 and estimates are …

Background There are no recent estimates of the incidence and mortality from cancer at a
European level. Those data that are available generally refer to the mid-1990s and are of …

Background Low-dose spiral CT of the chest effectively detects early-stage lung cancer in
high-risk individuals. The high rate of benign nodules and issues of making a differential …

Recent advances in medicine have dramatically reduced the incidence and mortality of
many cardiovascular, infectious, and certain neoplastic diseases; the overall mortality for …

Colorectal cancer (CRC) is the second most frequent malignant disease in Europe. Every
year, 412 000 people are diagnosed with this condition, and 207 000 patients die of it. In …

In this work we propose and investigate a family of models, which admits as particular cases
some well known mathematical models of tumor-immune system interaction, with the …

Preventable risk factors are responsible of at least 40% of cases and almost 45% of all
cancer deaths worldwide. Cancer is already the leading cause of death in almost half of the …

Proteomics analyses have been exploited for the discovery of novel biomarkers for the early
recognition and prognostic stratification of cancer patients. These analyses have now been …

BACKGROUND AND PURPOSE: Adequate and equitable access to radiotherapy (RT) must
be a reasonable health care goal for the EU. However, there are large variations among the …